Journal News

From the journals: JLR

Isha Dey
February 11, 2020

We offer a selection of papers recently published in the Journal of Lipid Research. Topics include interactions of the endocannabinoid pathway with the gut microbiome, a novel way to detect turnover of an essential acid in the brain and inhibiting fatty acid oxidation to treat insulin resistance.

Gut feeling: The endocannabinoidome and intestinal microbe connection

The endocannabinoidome is a complex signaling pathway consisting of several G protein-coupled receptors, metabolic enzymes and more than 20 lipid mediators. Recent research links this pathway to intestinal health. With the discovery of endocannabinoid receptors in the gut, mechanisms underlying crosstalk between such receptors and the gut microbiota are being investigated. Scientists have speculated that a dysregulated endocannabinoid system may lead to inflammatory bowel disease and colon cancer.

Gut-bacteria-800x600.jpg
The University of Chicago / NIH Flickr
Commensal bacteria (red) reside among the mucus (green) and epithelial cells (blue) of a mouse small intestine.

To take a deep dive into the interactions of the endocannabinoid pathway with the gut microbiome, Claudia Manca and researchers from Canada, Belgium and Italy investigated alterations in the endocannabinoidome in germ-free and conventionally housed mice, both juveniles and adults. Using transcriptomic analysis, they found that expression of several endocannabinoid receptors was reduced in the germ-free mice compared to conventionally housed ones. However, when fecal matter containing natural bacteria from healthy mice was transferred to the germ-free mice, this receptor expression was restored significantly.

Endocannabinoidome signalling tone can also be affected by the basal endocannabinoidome lipid mediator levels as well as receptor expression, so the authors used liquid chromatography-mass spectrometry lipidomics to analyze the different endocannabinoidome lipid mediators and found that their levels were altered substantially in the intestines of both kinds of mice. The levels of some of these molecules were significantly different under germ-free conditions and sensitive to the introduction of fecal matter from conventionally raised mice. Thus, germ-free and conventionally housed mice had differing global gene expression of endocannabinoidome.

The research shows that lack of gut microbiota significantly altered the levels of endocannabinoid receptors as well their effector molecules at the transcriptome level in the small and large intestines of mice. Published in the Journal of Lipid Research, this study provides evidence of direct interaction of the endocannabinoidome with gut microbiota and opens new avenues to investigate the pathophysiological role of endocannabinoid signaling.

A novel method to detect brain DHA turnover

Docosahexaenoic acid, or DHA, is essential for brain development in infants and normal functioning of adult brain. The brain can produce only a limited quantity of this polyunsaturated fatty acid, so it depends on a supply from circulating blood to replenish the metabolized DHA. Decreased DHA levels in the brain are associated with the onset of Alzheimer’s disease, making DHA metabolism in the brain an important topic of research. However, the existing method to study DHA turnover requires infusing stable isotope tracer-labeled fatty acid followed by tracing its metabolism kinetics. Not only is this approach expensive and complicated, but its limitations include inaccurate measurement of steady-state kinetics.

To circumvent these issues, R. J. Scott Lacombe and colleagues at the University of Toronto devised a tracer-free way of studying DHA turnover by measuring the ratio of natural 13C to 12C of DHA with high-precision gas chromatography combustion isotope ratio mass spectrometry. They fed mice with either alpha-linolenic acid or DHA for six weeks and then switched the fatty acids in their diets, followed by analyzing 13C to 12C DHA for another six months. Their results, published in the Journal of Lipid Research, correlate to findings using isotope tracers.

Treating insulin resistance: To err on the side of caution

In the pathological condition known as insulin resistance, cells fail to respond to insulin, resulting in increased blood glucose levels. This can result in increased risk of Type 2 diabetes, heart attacks, strokes and cancer. An underlying cause of this condition is an excess of circulating fatty acids, which promotes the oxidation of fat over glucose. Thus, inhibition of fatty acid oxidation, or FAOX, has been suggested as a treatment for insulin resistance.

Anne-Marie Lundsgaard and a team from Germany and Denmark performed a collaborative study to understand the consequences of inhibiting FAOX on overall metabolism. They used etomoxir to inhibit FAOX in mice, which in the short term resulted in increased glucose oxidation and lowered blood glucose as expected. However, within days, the treatment also resulted in triglyceride accumulation in the heart and liver. In fact, when etomoxir was administered to mice over a prolonged period, it resulted in hepatic steatosis or fatty liver disease and glucose intolerance. Their findings, published in the Journal of Lipid Research, shed light on the long-term consequences of FAOX inhibition for treating insulin resistance, which could move researchers to rethink such treatment strategies.

Isha Dey

Isha Dey is a scientist at Thermo Fisher Scientific in India.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

Sphingolipids show potential as biomarkers for multiple sclerosis
Journal News

Sphingolipids show potential as biomarkers for multiple sclerosis

December 01, 2020

Maria Podbielska and colleagues at the Hirszfeld Institute write in the Journal of Lipid Research about their finding that ceramide levels vary in active and inactive MS lesions in the nervous system.

World AIDS Day 2020
Health Observance

World AIDS Day 2020

December 01, 2020

Despite decades of research and amazing scientific advancements, HIV remains a global threat.

Will the coronavirus evolve to be less deadly?
News

Will the coronavirus evolve to be less deadly?

November 29, 2020

All pandemics eventually run their course. But history and science suggest many possible pathways. How might COVID-19 end?

Uncovering details of molecular Ferris wheels inside cell structures
News

Uncovering details of molecular Ferris wheels inside cell structures

November 28, 2020

Simulations on the nation’s fastest supercomputer confirm details of a molecular mechanism that cell organelles use to regulate the pH of their environment.

The NIH is turning the human reference genome into a pangenome
News

The NIH is turning the human reference genome into a pangenome

November 26, 2020

In 2000, the human genome was announced as completed. But it was filled with gaps, and did not represent humanity’s genetic diversity. Read and watch a short film about recent updates.

From the journals: MCP
Journal News

From the journals: MCP

November 25, 2020

A destructive disease can lurk in a citrus plant’s vascular system. Misfolded proteins offer a key to inflammation in liver disease. And proteomic studies provide clues about signaling linked to neurological disorders.